The price-to-earnings ratio for 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) is above average at 2.86x. The 36-month beta value for SXTP is also noteworthy at 4.69. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for SXTP is 1.52M, and at present, short sellers hold a 4.01% of that float. The average trading volume of SXTP on August 21, 2024 was 708.01K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SXTP) stock’s latest price update
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP)’s stock price has plunge by 16.41relation to previous closing price of 1.56. Nevertheless, the company has seen a 36.54% surge in its stock price over the last five trading sessions. zacks.com reported 2024-08-14 that 60 Degrees Pharmaceuticals Inc. (SXTP) came out with a quarterly loss of $4.23 per share versus the Zacks Consensus Estimate of a loss of $3.96. This compares to loss of $16.81 per share a year ago.
SXTP’s Market Performance
SXTP’s stock has risen by 36.54% in the past week, with a monthly drop of -17.93% and a quarterly drop of -45.78%. The volatility ratio for the week is 20.05% while the volatility levels for the last 30 days are 20.39% for 60 Degrees Pharmaceuticals Inc The simple moving average for the last 20 days is 11.43% for SXTP stock, with a simple moving average of -62.56% for the last 200 days.
SXTP Trading at -27.67% from the 50-Day Moving Average
After a stumble in the market that brought SXTP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.83% of loss for the given period.
Volatility was left at 20.39%, however, over the last 30 days, the volatility rate increased by 20.05%, as shares sank -16.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -57.74% lower at present.
During the last 5 trading sessions, SXTP rose by +33.08%, which changed the moving average for the period of 200-days by -75.00% in comparison to the 20-day moving average, which settled at $1.6123. In addition, 60 Degrees Pharmaceuticals Inc saw -85.16% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SXTP starting from DOW GEOFFREY S, who purchase 25,974 shares at the price of $0.38 back on Jan 31 ’24. After this action, DOW GEOFFREY S now owns 703,599 shares of 60 Degrees Pharmaceuticals Inc, valued at $9,740 using the latest closing price.
XU CHERYL, the Director of 60 Degrees Pharmaceuticals Inc, purchase 200,000 shares at $0.38 during a trade that took place back on Jan 31 ’24, which means that XU CHERYL is holding 424,934 shares at $75,000 based on the most recent closing price.
Stock Fundamentals for SXTP
Current profitability levels for the company are sitting at:
- -24.44 for the present operating margin
- -0.02 for the gross margin
The net margin for 60 Degrees Pharmaceuticals Inc stands at -4.14. The total capital return value is set at -2.88.
Based on 60 Degrees Pharmaceuticals Inc (SXTP), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -39.03. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is -206.22.
Currently, EBITDA for the company is -5.05 million with net debt to EBITDA at 0.5. When we switch over and look at the enterprise to sales, we see a ratio of 4.77. The receivables turnover for the company is 1.23for trailing twelve months and the total asset turnover is 0.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.08.
Conclusion
In summary, 60 Degrees Pharmaceuticals Inc (SXTP) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
